Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0000950170-24-079752

Options or other derivatives

  • Director acquired 1,144,686 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Behbahani Ali Director 2024-07-01 Grant or award · Option to purchase Ordinary Shares +1,144,686 1,144,686 D
Loading xslF345X05/ownership.xml…